Zhen-Hu Guo (Zhenhu Guo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Oxide Nanoparticles

Reactive Oxygen Species

Top Venues

Journal of materials chemistry. B

ACS applied materials & interfaces

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jing-Song Lu, Yupei Wang, Xiaohan Gao, Ying Li, Neema Ufurahi-Pambe, Abdul Fahad, Zeping Jin, Zhijun He, Zhen-Hu Guo, Wen-Sheng Xie, Shi Wang, Xiaodan Sun, Xiu-Mei Wang, Jing Yu, Shenglei Che, Guifeng Zhang, Yen Wei, Ling-Yun Zhao
Cancer nutritional-immunotherapy with NIR-II laser-controlled ATP release based on material repurposing strategy. Journal of materials chemistry. B 12 (19) (2024)
Zhen-Hu Guo, Xiaohan Gao, Jing-Song Lu, Ying Li, Zeping Jin, Abdul Fahad, Neema Ufurahi Pambe, Hirotaka Ejima, Xiaodan Sun, Xiu-Mei Wang, Wensheng Xie, Guifeng Zhang, Ling Yun Zhao
Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca 2+ /Cu 2+ Dual-Ions Nano Trap for Breast Cancer Treatment. ACS nano 18 (9) (2024)
Wensheng Xie, Ying Li, Zhen-Hu Guo, Jing-Song Lu, Guofeng Li, Ziyao Zhang, Fangming Zhang, Yen Wei, Xing Wang, Ling Yun Zhao
FePd Nanozyme- and SKN-Encapsulated Functional Lipid Nanoparticles for Cancer Nanotherapy via ROS-Boosting Necroptosis. ACS applied materials & interfaces (2024)
Wensheng Xie, Ying Li, Zhen-Hu Guo, Jing-Song Lu, Guofeng Li, Ziyao Zhang, Fangming Zhang, Yen Wei, Xing Wang, Ling Yun Zhao
FePd Nanozyme- and SKN-Encapsulated Functional Lipid Nanoparticles for Cancer Nanotherapy via ROS-Boosting Necroptosis. ACS applied materials & interfaces 16 (15) (2024)
Jing-Song Lu, Yupei Wang, Xiaohan Gao, Ying Li, Neema Ufurahi-Pambe, Abdul Fahad, Zeping Jin, Zhijun He, Zhen-Hu Guo, Wen-Sheng Xie, Shi Wang, Xiaodan Sun, Xiu-Mei Wang, Jing Yu, Shenglei Che, Guifeng Zhang, Yen Wei, Ling-Yun Zhao
Cancer nutritional-immunotherapy with NIR-II laser-controlled ATP release based on material repurposing strategy. Journal of materials chemistry. B 12 (19) (2024)
Zhen-Hu Guo, Xiaohan Gao, Jing-Song Lu, Ying Li, Zeping Jin, Abdul Fahad, Neema Ufurahi Pambe, Hirotaka Ejima, Xiaodan Sun, Xiu-Mei Wang, Wensheng Xie, Guifeng Zhang, Ling Yun Zhao
Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca 2+ /Cu 2+ Dual-Ions Nano Trap for Breast Cancer Treatment. ACS nano 18 (9) (2024)
Zhen-Hu Guo, Xiaohan Gao, Jing-Song Lu, Ying Li, Zeping Jin, Abdul Fahad, Neema Ufurahi Pambe, Hirotaka Ejima, Xiaodan Sun, Xiu-Mei Wang, Wensheng Xie, Guifeng Zhang, Ling Yun Zhao
Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca 2+ /Cu 2+ Dual-Ions Nano Trap for Breast Cancer Treatment. ACS nano (2024)
Wensheng Xie, Ying Li, Zhen-Hu Guo, Jing-Song Lu, Guofeng Li, Ziyao Zhang, Fangming Zhang, Yen Wei, Xing Wang, Ling Yun Zhao
FePd Nanozyme- and SKN-Encapsulated Functional Lipid Nanoparticles for Cancer Nanotherapy via ROS-Boosting Necroptosis. ACS applied materials & interfaces 16 (15) (2024)
Jing-Song Lu, Yupei Wang, Xiaohan Gao, Ying Li, Neema Ufurahi-Pambe, Abdul Fahad, Zeping Jin, Zhijun He, Zhen-Hu Guo, Wen-Sheng Xie, Shi Wang, Xiaodan Sun, Xiu-Mei Wang, Jing Yu, Shenglei Che, Guifeng Zhang, Yen Wei, Ling-Yun Zhao
Cancer nutritional-immunotherapy with NIR-II laser-controlled ATP release based on material repurposing strategy. Journal of materials chemistry. B (2024)
Wei Zhao, Jiabin Xu, Yuanyuan You, Zhen-Hu Guo, Yun Xiang, Kenan Hao, Xiaofeng He, Peng Zhao
Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma. Chemical communications (Cambridge, England) (2023)
Zhen-Hu Guo, Wen-Sheng Xie, Jing-Song Lu, Xiaoxiao Guo, Jianzhong Xu, Wanling Xu, Yongjie Chi, Nonaka Takuya, Hong Wu, Lingyun Zhao
Tannic acid-based metal phenolic networks for bio-applications: a review. Journal of materials chemistry. B 9 (20) (2021)
Xiao-Xiao Guo, Zhen-Hu Guo, Jing-Song Lu, Wen-Sheng Xie, Qiu-Zi Zhong, Xiao-Dan Sun, Xiu-Mei Wang, Jian-Ye Wang, Ming Liu, Ling-Yun Zhao
All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation. Nanoscale 13 (34) (2021)